ALB vs. WST
Compare and contrast key facts about Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALB or WST.
Correlation
The correlation between ALB and WST is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALB vs. WST - Performance Comparison
Key characteristics
ALB:
-0.42
WST:
-0.13
ALB:
-0.26
WST:
0.09
ALB:
0.97
WST:
1.01
ALB:
-0.31
WST:
-0.12
ALB:
-0.88
WST:
-0.24
ALB:
27.16%
WST:
20.12%
ALB:
57.70%
WST:
38.61%
ALB:
-77.22%
WST:
-55.52%
ALB:
-70.26%
WST:
-29.70%
Fundamentals
ALB:
$11.18B
WST:
$23.83B
ALB:
-$16.76
WST:
$6.74
ALB:
8.27
WST:
6.14
ALB:
$4.15B
WST:
$2.14B
ALB:
-$78.57M
WST:
$726.20M
ALB:
-$1.29B
WST:
$535.00M
Returns By Period
In the year-to-date period, ALB achieves a 9.57% return, which is significantly higher than WST's 0.44% return. Over the past 10 years, ALB has underperformed WST with an annualized return of 6.38%, while WST has yielded a comparatively higher 20.85% annualized return.
ALB
9.57%
-3.31%
1.40%
-20.64%
4.28%
6.38%
WST
0.44%
-0.47%
0.73%
-4.82%
16.21%
20.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALB vs. WST — Risk-Adjusted Performance Rank
ALB
WST
ALB vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ALB vs. WST - Dividend Comparison
ALB's dividend yield for the trailing twelve months is around 1.71%, more than WST's 0.25% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALB Albemarle Corporation | 1.71% | 1.87% | 1.11% | 0.73% | 0.67% | 1.04% | 2.02% | 1.74% | 1.00% | 1.42% | 2.07% | 1.83% |
WST West Pharmaceutical Services, Inc. | 0.25% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
ALB vs. WST - Drawdown Comparison
The maximum ALB drawdown since its inception was -77.22%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for ALB and WST. For additional features, visit the drawdowns tool.
Volatility
ALB vs. WST - Volatility Comparison
Albemarle Corporation (ALB) has a higher volatility of 12.05% compared to West Pharmaceutical Services, Inc. (WST) at 6.40%. This indicates that ALB's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ALB vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Albemarle Corporation and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities